New from #CSO_Scotland https://t.co/jtyFw26uXq Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism
Hm. Vreemde conclusie. Abstract is niet erg inzichtgevend. #Rivaroxaban studie VS aspirine was ook provoked #VTE en waar is #apixaban studie? @gjgeersing https://t.co/f6lo4hiUlW
New #CochraneEvidence 'Secondary prevention of recurrent #VTE after initial oral anticoagulation therapy in patients with unprovoked VTE' @ClotRecoveryNet @StopTheClot https://t.co/Y9TTIj0NXh
New #CochraneEvidence 'Secondary prevention of recurrent #VTE after initial oral anticoagulation therapy in patients with unprovoked VTE' @NNMN1 @vascularnurses @McGillVascular https://t.co/Y9TTIj0NXh
New #CochraneEvidence with link! 'Secondary prevention of recurrent #VTE after initial oral anticoagulation therapy in patients with unprovoked VTE https://t.co/Y9TTIj0NXh
RT @rincondesisifo: (Cochrane) Seguridad y eficacia de la prolongación del tto anticoagulante en la prevención 2ª de TEV https://t.co/1elR2…
(Cochrane) Seguridad y eficacia de la prolongación del tto anticoagulante en la prevención 2ª de TEV https://t.co/1elR2bHnrW
The safety and effectiveness of extending anticoagulant treatment for people who have been… https://t.co/TGC8OcYIa9
Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation… https://t.co/XI3o64ynOM